Literature DB >> 2788983

Planar positron imaging of rubidium-82 for myocardial infarction: a comparison with thallium-201 and regional wall motion.

K A Williams1, J W Ryan, L Resnekov, V Stark, E L Peterson, G C Gustafson, W B Martin, P A Freier, P V Harper.   

Abstract

Rubidium-82 (Rb-82) is a generator-produced, short half-life (76 seconds) positron emitting potassium analog. Using a mobile gamma camera equipped with a rotating tungsten collimator and high-energy shielding, we examined the use of Rb-82 in the coronary care unit and clinical laboratory for detection of perfusion defects due to myocardial infarction. We studied 31 subjects, 10 patients with acute myocardial infarction, 12 with remote myocardial infarction, and nine controls. Rb-82 images were compared with Tl-201 and regional wall motion for detection of infarct-related arteries. Of the 22 patients with myocardial infarction, 16 were identified with Rb-82 and Tl-201. In nine control subjects, eight were normal with each method. Correlation between Rb-82 and Tl-201 defect scores was excellent. Sensitivity and specificity for infarct-related arteries were similar for Rb-82, Tl-201, and wall motion imaging. Thus planar Rb-82 imaging can detect MI reliably in the coronary care unit and in the clinical laboratory.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788983     DOI: 10.1016/0002-8703(89)90277-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

Review 1.  Fluorine 18-labeled fluorodeoxyglucose myocardial scintigraphy with Anger gamma cameras for assessing myocardial viability.

Authors:  M J Kelly; V Kalff
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

2.  PET in clinical cardiology: can we already swim?

Authors:  J A Blokland; E K Pauwels; E E van der Wall
Journal:  Eur J Nucl Med       Date:  1990

Review 3.  Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability.

Authors:  M P Sandler; J A Patton
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.